Providing novel therapies to patients in the community setting and participating in landmark clinical trials are core to the mission of The US Oncology Network.
US Oncology Research forms one of the nation’s largest research networks specializing in Phase I–IV oncology clinical trials. Our investigator- and sponsor-initiated trials bring innovative therapies to patients in local communities across the nation.
Here are a few facts about US Oncology Research: • US Oncology Research serves more than 85 practices in 250 locations. • At any given time, we typically have over 200 active trials. • More than 53,000 patients have participated in trials offered by US Oncology Research. • US Oncology Research has contributed to the development of 43 cancer therapies approved by the FDA.
Research Leadership
US Oncology Research is physician led and physician driven. Physicians select the trials in which they want to enroll patients, based on the community they serve and the scientific merit of the question to be answered in the clinical trial.
Physician leadership of US Oncology Research includes:
US Oncology Research Leaders:
Daniel Von Hoff, M.D. Chief Scientific Officer, US Oncology Research Director of the Translational Oncology (Early Phase) Program
Stephen Jones, M.D. Medical Director, US Oncology Research Co-chair of the Breast Committee
Disease Committee Chairs:
Breast Cancer Joyce O’Shaughnessy Stephen Jones Frankie A. Holmes John W. Smith
Developmental Therapeutics Nicholas Vogelzang C. Lance Cowey Parvesh Kumar
Gastrointestinal Cancer Donald Richards Thomas Cartwright Allen Cohn
Genitourinary Cancer Nicholas Vogelzang Thomas Hutson
Gynecologic Cancer Michael Teneriello
Hematologic Cancer Nicholas DiBella Kathryn Kolibaba Jeff Sharman
Lung Cancer Craig Reynolds David Smith Robert Jotte
Translational Oncology Program Daniel Von Hoff Carlos Becerra
Radiation Therapy Vivek Kavadi
Research Leadership Opportunities US Oncology Research has many research leadership opportunities, including roles as study principal investigators, site research leaders and participation in national disease committees. These roles have been pivotal in making US Oncology Research what it is today.
Publication Assistance Our biostatistics and medical writing services team assist physicians in taking investigator-initiated trials from concept to publication. US Oncology Research has produced over 57 manuscripts from investigator-initiated studies that have been published in peer-reviewed journals.
US Oncology Research publication and presentation accomplishments from 1999–2010 include:
Meetings
Abstracts
Posters
Oral Presentations
ASCO
88
54
4
SABCS
41
28
7
ASH
12
3
1
World Lung Cancer
12
9
4
Inv meetings
23
2
16
Pan Pacific
2
1
0
ASBMTR
3
2
1
ESMO/IASLC/World GI
7
6
1
ISPOR
2
2
-
ISOG
2
-
-
TOTAL
192
107
34
Integrating Research and Healthcare Technology Practices affiliated with US Oncology Research utilize several technological tools to more easily match patients to clinical trials.
iKnowMedTM is an oncology-focused electronic health record (EHR). After the staging and diagnosis process is complete or updated, iKnowMed automatically screens the patient’s record for potential clinical trial eligibility. This helps physicians using iKnowMed increase participation in open clinical trials at their practice, and assists with the selection of the appropriate treatment regimen at the point of care.
The healthcare technology also helps identify patients who may qualify for open trials through US Oncology Research’s Comprehensive Accrual Resource, or “CARE.” At the practice’s request, CARE enables a search of the practice’s patient records in the iKnowMed EHR to find potential matches for open trials at the practice for patients currently on treatment, post-treatment, or even before treatment begins. This resource can help the practice increase accruals while saving valuable time.
Join The Network Learn how participating in The US Oncology Network can benefit you and your practice. Learn More
